Inclusion Criteria:
Informed consent was signed before the trial, healthy male and female
subjects aged between 18 and 45 (inclusive) at the time of signing the
informed consent, of which no less than 1/3 are female subjects.
Subjects have no childbirth plans and agree to take effective
contraceptive measures within 6 months of the last medication, the blood
pregnancy test for women of child bearing age must be negative before
taking the study drug; The serum HCG test of fertile women must be
negative before screening. the bodyweight of male subjects was ≥50 kg,
and that of females was≥45 kg; The body mass index should range between
19–28 kg/m2, the bodyweight of male subjects was ≥50
kg, and that of females was≥45 kg; the body mass index should range
between 19–24 kg/m2((inclusive); Creatinine clearance
(CLCr) ≥80 mL/min, and creatinine is less than or equal to the upper
limit of normal value.